Atlas Venture Fund X, L.P.

Insider profile

Performance

Overall performance
3.3

Performance over holding periods
3.3
30 days 90 days 120 days
Average return 3% 8.2% 15.1%
Success rate 55% 68% 82%
Transactions
36 0% Buy
34 71% Buy
47 69% Buy
Atlas Venture Fund X, L.P.'s trades of Kymera Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-04-22 2026-04-22 PrS Proposed sale
41,407
212.89
US$1,238,659
41,407 212.89 US$1,238,659
2026-04-15 2026-04-15 PrS Proposed sale
65,793
430.70
US$4,698,734
65,793 430.70 US$4,698,734
2026-03-02 2026-03-02 PrS Proposed sale
52,142
345.00
US$1,719,169
52,142 345.00 US$1,719,169
2025-12-17 2025-12-17 PrS Proposed sale
818
91.47
US$74,822
818 91.47 US$74,822
2025-12-16 2025-12-16 PrS Proposed sale
22,666
92.00
US$2,085,272
22,666 92.00 US$2,085,272
2025-12-16 2025-12-16 PrS Proposed sale
52,000
91.47
US$4,756,440
52,000 91.47 US$4,756,440
2025-12-15 2025-12-15 PrS Proposed sale
32,035
91.85
US$2,942,415
32,035 91.85 US$2,942,415
2025-12-15 2025-12-15 PrS Proposed sale
36,877
92.00
US$3,392,684
36,877 92.00 US$3,392,684
2025-12-12 2025-12-12 PrS Proposed sale
49,299
93.60
US$4,614,386
49,299 93.60 US$4,614,386
2025-12-12 2025-12-12 PrS Proposed sale
570
89.68
US$51,118
570 89.68 US$51,118
2025-12-11 2025-12-11 PrS Proposed sale
5,125
87.81
US$450,026
5,125 87.81 US$450,026
2025-12-10 2025-12-10 PrS Proposed sale
193,040
89.89
US$17,352,366
193,040 89.89 US$17,352,366
2025-10-17 2025-10-17 PrS Proposed sale
50,000
74.36
US$3,718,000
50,000 74.36 US$3,718,000
2025-10-16 2025-10-16 PrS Proposed sale
1,425
76.98
US$109,696
1,425 76.98 US$109,696
2025-10-15 2025-10-15 PrS Proposed sale
22,160
73.00
US$1,617,680
22,160 73.00 US$1,617,680
2025-08-22 2025-08-22 PrS Proposed sale
4,080
59.75
US$243,780
4,080 59.75 US$243,780
2025-08-14 2025-08-14 PrS Proposed sale
12,862
61.10
US$785,868
12,862 61.10 US$785,868
2025-08-13 2025-08-13 PrS Proposed sale
44,520
59.03
US$2,628,016
44,520 59.03 US$2,628,016
2025-08-05 2025-08-05 PrS Proposed sale
705
59.79
US$42,152
705 59.79 US$42,152
2025-07-30 2025-07-30 PrS Proposed sale
15,146
59.80
US$905,731
15,146 59.80 US$905,731
2025-07-24 2025-07-24 PrS Proposed sale
23,245
60.94
US$1,416,550
23,245 60.94 US$1,416,550
2025-07-23 2025-07-23 PrS Proposed sale
53,215
60.74
US$3,232,279
53,215 60.74 US$3,232,279
2025-07-18 2025-07-18 PrS Proposed sale
1,184
57.79
US$68,423
1,184 57.79 US$68,423
2025-02-05 2025-02-05 PrS Proposed sale
112,211
54.32
US$6,095,302
112,211 54.32 US$6,095,302
2025-02-04 2025-02-04 PrS Proposed sale
6,350
54.99
US$349,186
6,350 54.99 US$349,186
2025-02-03 2025-02-03 PrS Proposed sale
6,439
55.80
US$359,296
6,439 55.80 US$359,296
2024-07-09 2024-07-09 PrS Proposed sale
375,184
31.96
US$11,990,881
375,184 31.96 US$11,990,881
2024-06-13 2024-06-13 PrS Proposed sale
8,430
34.60
US$291,678
8,430 34.60 US$291,678
2024-06-12 2024-06-12 PrS Proposed sale
13,835
34.57
US$478,276
13,835 34.57 US$478,276
2024-03-15 2024-03-15 PrS Proposed sale
59,310
39.51
US$2,343,338
59,310 39.51 US$2,343,338
2024-03-14 2024-03-14 PrS Proposed sale
46,100
42.30
US$1,950,030
46,100 42.30 US$1,950,030
2024-03-13 2024-03-13 PrS Proposed sale
115,090
41.85
US$4,816,516
115,090 41.85 US$4,816,516
2024-03-13 2024-03-13 PlS Planned sale
1,386 -0.2%
42.84
US$59,376
1,386 -0.2% 42.84 US$59,376
2024-03-13 2024-03-13 PlS Planned sale
22,779 -2.7%
42.19
US$961,046
22,779 -2.7% 42.19 US$961,046
2024-03-13 2024-03-13 PlS Planned sale
6,686 -0.1%
42.84
US$286,428
6,686 -0.1% 42.84 US$286,428
2024-03-13 2024-03-13 PlS Planned sale
108,404 -2.3%
42.19
US$4,573,565
108,404 -2.3% 42.19 US$4,573,565
2024-03-13 2024-03-12 PlS Planned sale
1,819 -0.2%
42.52
US$77,344
1,819 -0.2% 42.52 US$77,344
2024-03-13 2024-03-12 PlS Planned sale
26,452 -3.0%
41.94
US$1,109,397
26,452 -3.0% 41.94 US$1,109,397
2024-03-13 2024-03-12 PlS Planned sale
8,581 -0.2%
42.52
US$364,864
8,581 -0.2% 42.52 US$364,864
2024-03-13 2024-03-12 PlS Planned sale
126,066 -2.6%
41.94
US$5,287,208
126,066 -2.6% 41.94 US$5,287,208
2024-03-12 2024-03-12 PrS Proposed sale
134,647
42.29
US$5,694,222
134,647 42.29 US$5,694,222
2024-03-13 2024-03-11 PlS Planned sale
1,045 -0.1%
43.42
US$45,374
1,045 -0.1% 43.42 US$45,374
2024-03-13 2024-03-11 PlS Planned sale
7,837 -0.9%
42.77
US$335,188
7,837 -0.9% 42.77 US$335,188
2024-03-13 2024-03-11 PlS Planned sale
5,122 -0.1%
43.42
US$222,397
5,122 -0.1% 43.42 US$222,397
2024-03-13 2024-03-11 PlS Planned sale
37,180 -0.7%
42.77
US$1,590,189
37,180 -0.7% 42.77 US$1,590,189